Neuren Pharmaceuticals Limited (ASX:NEU) PERFORMANCE ANALYSIS IN FOCUS:
Neuren Pharmaceuticals Limited (ASX:NEU) stock has changed AUD$ 0 and moved 0% whereas stock price touched at AUD$ 1.07 in last trading session. 40270 shares exchanged at hands while it’s an average volume stands with 72429 shares. The company recorded relative volume of 0.56. When an analyst or an investor is researching a stock, it’s good to know what other investors think about it. After all, they might have some additional insight into the company or they might be creating a trend. Most popular methods for gauging market sentiment is to take a look at the recently traded volume.
Neuren Pharmaceuticals Limited (ASX:NEU) has performed -9.322034% around last month and performed -20.740741% over the last quarter. The stock showed return of -23.571429% over five years and registered weekly return of -4.464286%. The stock has been watched at -63.973064% return throughout last twelve months.
Tracking last 52 weeks, the stock 52 week high price observed at AUD$ 3.48 and 52 week low seen at AUD$ 1.005. The 50 SMA is AUD$ 1.152778 and 200 SMA is AUD$ 1.292571. Moving averages can be used as support or resistance when a trader looks for a possible entry or exit in the market. This can also be said in the following way. In case the price makes a contact with the moving average on the price chart, the trader, examining closely this chart, will enter either into a long, or into a short position. Actually, this works in the same way as horizontal support or resistance lines. Moving averages are known as dynamic support and resistance, simply because they tend to change with prices.
Analyst recommended consensus rating of 2 on this stock. Analysts also expected that stock to achieve share value at AUD$ 2.28 in coming one year period. EBITDA is AUD$ 4124400. EBITDA is a company’s earnings before interest, taxes, depreciation, and amortization and is an accounting measure calculated using a company’s net earnings, before interest expenses, taxes, depreciation and amortization are subtracted, as a proxy for a company’s current operating profitability.
The company made Revenue of AUD$ 9793000. Revenue is also referred to as sales or turnover. Some companies receive revenue from interest, royalties, or other fees. Revenue may refer to business income in general, or it may refer to the amount, in a monetary unit, earned during a period of time. Net Income of the company is AUD$ 2151100. Net Income Available for Common Shareholders equals net income minus preferred dividends paid. Net income available to common shareholders are the profits remaining after the company pays all of its suppliers, employees, service providers, creditors, and preferred shareholders. In other words, this is revenue less all expenses and preferred dividends. The number measures common shareholders’ claim on the company’s cash flows.
Return on capital employed (ROCE) is 23.57%. Return on capital employed (ROCE) is a financial ratio that measures a company’s profitability and the efficiency with which its capital is used. Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders’ equity and debt liabilities. It can be simplified as total assets minus current liabilities.
The current ratio is 13.502. The current ratio is the classic measure of liquidity. It indicates whether the business can pay debts due within one year out of the current assets. The quick ratio is 12.427. 1:1 shows the business can meet its current financial obligations with quick funds on hand. A ratio lower than 1:1 may indicate that the company relies too much on inventory or other assets to pay its short-term liabilities.
Volatility or average true range percent (ATRP 14) is 2.78%. The ATR expressed as a percentage of closing price. Average true range percent (ATRP) measures volatility on a relative level. ATRP allows securities to be compared whereas ATR does not. That means lower-priced stocks won’t necessarily have lower ATR values than higher-priced stocks. The stock beta value watched at 1.234442. Beta measures the amount of market risk associated with market trade. High beta reveals more riskiness and low beta shows low risk.
Tracking profitability check, the firm profit margin which was recorded at 21.97% and operating margin noted at 41.57%. The company maintained a Gross Margin of 56.39%. The Company has been able to maintain return on asset (ROA) at 16.30% for the last twelve months. Return on equity (ROE) recorded at 14.98%.
Headquarters Location of Neuren Pharmaceuticals Limited (ASX:NEU) is Australia. P/E ratio is noted at 34.516132. P/E is a popular valuation ratio of a company’s current share price compared to its per-share earnings (trailing twelve months). P/S ratio of 7.66117 reflects the value placed on sales by the market. P/B ratio is 4.349594. P/B is used to compare a stock’s market value to its book value. It has a market cap of AUD$ 75025837.6. Using market capitalization to show the size of a company is important because company size is a basic determinant of various characteristics in which investors are interested, including risk.
Now The company has RSI figure of 36.85. RSI compares the magnitude of recent gains to recent losses to see if an asset is oversold or overbought. RSI is plotted on a scale of 0-100. Generally, if it is above 70, the stock is considered overbought and so one can look to sell it. Similarly, an RSI of less than 30 indicates the stock is oversold and can be bought.
ADX value listed at 17.21. ADX indicator measures strong or weak trends. This can be either a strong uptrend or a strong downtrend. It does not tell you if the trend is up or down, it just tells you how strong the current trend is! If ADX is between 0 and 25 then the stock is in a trading range. It is likely just chopping around sideways. Avoid these weak, pathetic stocks! Once ADX gets above 25 then you will begin to see the beginning of a trend. Big moves (up or down) tend to happen when ADX is right around this number. /p>
When the ADX indicator gets above 30 then you are staring at a stock that is in a strong trend! These are the stocks that you want to be trading! You won’t see very many stocks with the ADX above 50. Once it gets that high, you start to see trends coming to an end and trading ranges developing again.
David Culbreth – Category – Business
David Culbreth is a self-taught investor that has been investing in equities since she was a senior in college and continues to invest. He is extremely devoted to demystifying investing terminology for new investors.
David Culbreth is a senior author and journalist. He has more than 5 years of experience in institutional investment markets, including fixed income, equities, derivatives and real estate. David has a Bachelor in Business Administration with a major in Finance. He bought his first stocks in a private business at age 15 and made his first public stock trade at 23. He has always been interested in the stock market and how it behaves.
As the dad of two children, he’s made saving money and investing for them a high priority. Over many years of investing, he has made some wise choices and he’s made many mistakes. But he’s learned from both. Mr. David observations and experience give him the insight to stock market patterns and the investor behaviors that create them.